Services, storage, and shipping to obtain HLA-B27+ healthy control biospecimens national institute of arthritis and musculoskeletal and skin diseases (niams). These samples will serve as controls…
Ended Purchase Order Awarded Last action
- Contract number
- 75N92024P00333
- Awardee
-
Discovery Life Sciences, LLC UEI GDJDUFGMSC14
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $28,690
Award facts
- Contract value 100% obligated
- $28,690.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Insititue of Arthritis and Musculoskeletal and Skin Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Huntsville, AL 35806, USA
Award details come from SAM.gov/FPDS.
About this award
This is a $28,690 firm-fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to Discovery Life Sciences, LLC, a small disadvantaged business. The contract is for services, storage, and shipping to obtain HLA-B27+ healthy control biospecimens. These samples will serve as controls for NIAMS's cohort of patients with HLA-B27+ axial conditions. The contract has a period of performance through March 12, 2025. Discovery Life Sciences has provided diverse research products and services to federal agencies in the past, including biospecimen procurement, genomic sequencing, and bioanalytical services. This award was not set aside for a specific business category.
Description
Services, storage, and shipping to obtain HLA-B27+ healthy control biospecimens national institute of arthritis and musculoskeletal and skin diseases (niams). These samples will serve as controls for the agency cohort of patients with HLA-B27+ axial
Quick answers
Who was awarded contract 75N92024P00333?
75N92024P00333 was awarded to Discovery Life Sciences, LLC by National Heart Lung and Blood Institute (National Institutes of Health) on September 13, 2024.
How much is contract 75N92024P00333 worth?
The government has obligated $28,690 on 75N92024P00333.
Which agency awarded contract 75N92024P00333?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92024P00333, with funding from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health).
Was contract 75N92024P00333 competed?
The extent of competition for 75N92024P00333 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award